2020 LMG Life Sciences Awards shortlists announced
August 04, 2020
Winners will be announced on Sept. 23 as a virtual event
US
Product Liability
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Walsh, Alexandra | Non-IP Litigation & Enforcement | Product Liability | Washington, D.C. |
| Wilkinson, Beth | Non-IP Litigation & Enforcement | Product Liability | Washington, D.C. |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Non-IP Litigation & Enforcement
Wilkinson Walsh & Eskovitz
A litigation boutique that opened in 2016 with the unwavering mission to dedicate itself to high-stakes trial work, Wilkinson Walsh has seen an astonishing rise in profile since its beginnings by fully making good on its ambitions. Washington, DC-based national celebrity trial lawyer Beth Wilkinson, who forged this firm upon decamping from her former post at Paul Weiss, has been at the forefront of precedent-setting jury trials of any stripe, but a sizeable portion of her work, as well as that of her DC and Los Angeles-based team, has been in the pharmaceutical world.
Of most recent note, in January 2018 Wilkinson and fellow name partner Alexandra Walsh, triumphed for Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals in the first state-court bellwether trial over the blood-thinner Xarelto. Plaintiffs alleged that the Xarelto label did not adequately instruct doctors on the risks of bleeding associated with the anticoagulant. Brian Stekloff, won the second state-court bellwether trial over Xarelto, and, in August 2018, Walsh led the team that won the third.
Articles
Winners will be announced on Sept. 23 as a virtual event